BioCryst Pharmaceuticals | BCRX - Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
BioCryst Pharmaceuticals USD 11.46M 501K 2026-06
Chugai Pharma JPY 160.7B 53.18B 2026-06
Daiichi Sankyo JPY 539.05B 57.81B 2026-06
DBV Technologies USD 39.5M 1.44M 2026-03
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
Glaxosmithkline GBP 14.34B 6.39B 2026-03
Incyte USD 1.39B 1.16B 2026-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
Karyopharm Therapeutics USD 4.28M 276K 2026-03
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novavax USD 22.94M 6.84M 2026-06
PTC Therapeutics USD 40.45M 14.96M 2026-06
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sarepta Therapeutics USD 50.98M 19.39M 2026-06
Ultragenyx Pharmaceutical USD 39M 3M 2026-06
Vertex Pharmaceuticals USD 3.61B 135M 2026-06